Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
GLP-1 Agonists and Risk of Atrial Fibrillation in Non-Dialysis Chronic Kidney Disease
Cardiovascular drugs and therapy, 2026
Current Concepts in Perioperative Guidance and Outcomes in Hand Surgery Patients Taking Glucagon-Like Peptide-1 Receptor Agonists
The Journal of hand surgery, 2026
Resmetirom and semaglutide therapy for patients with MAFLD in the MENA region: expert panel recommendations
Expert review of endocrinology & metabolism, 2026;:1-9
Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026
PCSK5 promotes angiogenesis and cardiac repair after myocardial infarction
Nature communications, 2026;17(1)
Wernicke’s Encephalopathy Following Semaglutide Treatment for Obesity: A Systematic PRISMA Review of Case-Based Evidence
Obesity (Silver Spring, Md.), 2026
GLP-1 receptor agonists in ADPKD: from metabolic rationale to phenotype-enriched translational testing
Translational research : the journal of laboratory and clinical medicine, 2026
Sexual function is missing from the adverse-effect map of GLP-1 receptor agonists in dermatology
Journal of the American Academy of Dermatology, 2026
Comparative 24-month cardiovascular outcomes and biomarker trajectories with semaglutide, empagliflozin, and sitagliptin in people with obesity and type 2 diabetes: a multicenter real-world study
Therapeutic advances in endocrinology and metabolism, 2026;17:20420188261460592
Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report
Frontiers in surgery, 2026;13:1859548
GLP-1 Receptor Agonists in Cardiac Surgery: From Metabolic Drug to Potential Perioperative Cardioprotective Agent
Journal of cardiovascular development and disease, 2026;13(7)
Females Are Completely Resistant to Semaglutide-Induced Muscle Loss in ob/ob Mice
Diabetes, 2026
Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial
Current opinion in cardiology, 2026
Enhanced Stability and Transdermal Delivery of Semaglutide Using an L-Arginine Based Dissolving Microneedle System
AAPS PharmSciTech, 2026;27(5)
Semaglutide and Musculoskeletal Health: A Mendelian Randomization Study Based on GLP-1 Receptor Expression
Endocrine, metabolic & immune disorders drug targets, 2026
Tirzepatide-Induced Functional Small Bowel Obstruction in a Surgically Naïve Patient: A Case Report
Clinical case reports, 2026;14(7):e73085
Direct effects of glucagon-like Peptide-1 receptor agonists on mitochondrial function in human-derived in vitro models: A systematic review and meta-analysis
Metabolism open, 2026;31:100484
Evidence That Semaglutide Represents an Important Tool for Treatment of Irregular Menses and Chronic Anovulation in Women with Polyendocrine Metabolic Ovarian Syndrome
Journal of clinical medicine, 2026;15(13)
Postshortage Compounded GLP-1 RA Market in 2 States With Potentially High Demand
JAMA health forum, 2026;7(7):e262207
Incretin-based cardiovascular protection beyond diabetes: evidence, mechanisms, and therapeutic frontiers from GLP-1 receptor agonists to multi-agonist therapy
Frontiers in endocrinology, 2026;17:1870649